NVIDIA BioNeMo Explained: Generative AI in Drug Discovery
Learn what NVIDIA BioNeMo is and how it accelerates drug discovery. This guide explains its components, models, and deployment for generative AI in biopharma.
Back to Articles
Articles tagged with “ai-in-pharma”
RLHF in Drug Discovery Models: Architecture & QA Explained
Explore the technical architecture of RLHF for drug discovery. Learn how reward models and policy optimization align generative AI with expert chemist feedback.
The EU AI Act & Pharma: Compliance Guide + Flowchart
Learn about the EU AI Act's impact on pharma. This guide explains the risk-based approach, high-risk AI rules, and compliance steps with a free flowchart & SOP
Pharma's AI Skills Gap: A 2025 Data-Driven Analysis
Our 2025 report analyzes the critical AI skills gap in the pharmaceutical industry, detailing the talent shortage with data and exploring key solutions.
GPTeal: Merck’s Generative AI Strategy for Pharma R&D
An in-depth analysis of Merck's GPTeal, a secure generative AI platform. Learn how it uses LLMs to accelerate pharmaceutical R&D and boost productivity.
AstraZeneca's ChatGPT Strategy: An Enterprise AI Case Study
An in-depth case study of AstraZeneca's ChatGPT and generative AI implementation. Analyze its enterprise strategy, use cases in pharma R&D, and results.
IQVIA CRM vs. Veeva CRM in Pharma: An In-Depth Comparison
A comprehensive comparison of IQVIA's Orchestrated Customer Engagement (OCE) and Veeva CRM platforms, analyzing features, integrations, usability, support, compliance, security, mobile capabilities, scalability, and user feedback for pharmaceutical organizations.